Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | CPA1 | P15085 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | FPR2 | P25090 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3703074 | 1.00 | ALDH1A1 (0.48) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL3703076 | 1.00 | ALDH1A1 (0.48) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL3635434 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL3635433 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL3635439 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL10137041 | 0.83 | ENPEP (0.47) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL15302507 | 0.83 | ALDH1A1 (0.68) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL15302508 | 0.83 | ALDH1A1 (0.68) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL5520878 | 0.82 | ENPEP (0.46) | ALDH1A1ENPEPL3MBTL1MMEACE | |
| SCHEMBL12763601 | 0.82 | ENPEP (0.52) | ALDH1A1ENPEPL3MBTL1MMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8541462-B2 | Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors | AETERNA ZENTARIS GMBH (DE) | 2013-09-24 | — | — | US | disclosed |
| US-8273716-B2 | Use of LHRH antagonists for intermittent treatments | SPECTRUM PHARMACEUTICALS, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| US-20120122763-A1 | NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS | AETERNA ZENTARIS GMBH (DE) | 2012-05-17 | — | — | US | disclosed |
| CN-101657211-A | Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity | AETERNA ZENTARIS GMBH DE | 2010-02-24 | — | — | CN | disclosed |
| US-20090221569-A1 | USE OF LHRH ANTAGONISTS FOR INTERMITTENT TREATMENTS | AETERNA ZENTARIS GMBH (DE) | 2009-09-03 | — | — | US | disclosed |
| EP-2095818-A1 | Use of LHRH antagonists at non-castrating doses | AEterna Zentaris GmbH (DE) | 2009-09-02 | — | — | EP | disclosed |
| US-20090170783-A1 | NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS | AETERNA ZENTARIS GMBH (DE) | 2009-07-02 | — | — | US | disclosed |
| US-20090075937-A1 | LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS | AETERNA ZENTARIS GMBH (DE) | 2009-03-19 | — | — | US | disclosed |
| EP-1988098-A1 | Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors | AEterna Zentaris GmbH (DE) | 2008-11-05 | — | — | EP | disclosed |
| US-7375127-B2 | Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) | AE ZENTARIS GMBH (DE) | 2008-05-20 | — | — | US | disclosed |
| US-20060014818-A1 | Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT | 2006-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170783-A1 | NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS | GPR88, GPR34, GPR27 | ALDH1A1 1733/4885ENPEP 2816/4885L3MBTL1 3550/4885 |
| US-20090221569-A1 | USE OF LHRH ANTAGONISTS FOR INTERMITTENT TREATMENTS | GNRHR, LHCGR, GHRHR | ALDH1A1 2497/4885ENPEP 181/4885L3MBTL1 555/4885 |
| US-20090075937-A1 | LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS | LHCGR, GNRHR, FSHR | ALDH1A1 727/4885ENPEP 176/4885L3MBTL1 712/4885 |
| US-20120122763-A1 | NOVEL TETRAHYDROCARBAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS | GPR88, GPR34, GPR27 | ALDH1A1 1733/4885ENPEP 2816/4885L3MBTL1 3550/4885 |
| US-20060014818-A1 | Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) | GPR88, GPR34, GPR35 | ALDH1A1 3119/4885ENPEP 1922/4885L3MBTL1 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.